Use of recombinant human bone morphogenetic protein-2 in spinal fusion applications.
about
Regulation of integrin and growth factor signaling in biomaterials for osteodifferentiationIn silico Mechano-Chemical Model of Bone Healing for the Regeneration of Critical Defects: The Effect of BMP-2Ex vivo transfer of the Hoxc-8-interacting domain of Smad1 by a tropism-modified adenoviral vector results in efficient bone formation in a rabbit model of spinal fusion.Effect of grafting BMP2-derived peptide to nanoparticles on osteogenic and vasculogenic expression of stromal cellsInjectable and compression-resistant low-viscosity polymer/ceramic composite carriers for rhBMP-2 in a rabbit model of posterolateral fusion: a pilot study.Use of carboxymethyl cellulose and collagen carrier with equine bone lyophilisate suggests late onset bone regenerative effect in a humerus drill defect - a pilot study in six sheep.pHEMA-nHA encapsulation and delivery of vancomycin and rhBMP-2 enhances its role as a bone graft substitute.Electrical stimulation therapies for spinal fusions: current concepts.Nell-1 protein promotes bone formation in a sheep spinal fusion model.Experimental and computational investigation of the effect of hydrophobicity on aggregation and osteoinductive potential of BMP-2-derived peptide in a hydrogel matrixEnhanced osteogenesis of adipose derived stem cells with Noggin suppression and delivery of BMP-2.Spatial regulation of controlled bioactive factor delivery for bone tissue engineering.Repair of a calvarial defect with biofactor and stem cell-embedded polyethylene glycol scaffold.Spine fusion by gene therapy.Applications of microscale technologies for regenerative dentistry.Novel Wnt Regulator NEL-Like Molecule-1 Antagonizes Adipogenesis and Augments Osteogenesis Induced by Bone Morphogenetic Protein 2A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE Bone Graft).Recombinant Human Bone Morphogenetic Protein-2 in Posterolateral Spinal Fusion: What's the Right Dose?2011 AOA Symposium: Tissue Engineering and Tissue Regeneration: AOA critical issues.Release characteristics and osteogenic activity of recombinant human bone morphogenetic protein-2 grafted to novel self-assembled poly(lactide-co-glycolide fumarate) nanoparticles.Novel microhydroxyapatite particles in a collagen scaffold: a bioactive bone void filler?The use of recombinant human BMP-2 as a salvage procedure in the pediatric spine: a report on 3 cases.The role of NELL-1, a growth factor associated with craniosynostosis, in promoting bone regeneration.Axially vascularized bone substitutes: a systematic review of literature and presentation of a novel model.Recombinant human bone morphogenetic protein-2 versus autogenous iliac crest bone graft for lumbar fusion: a meta-analysis of ten randomized controlled trials.Current overview on challenges in regenerative endodonticsA review paper on biomimetic calcium phosphate coatings.Bone morphogenetic protein use in spine surgery-complications and outcomes: a systematic review.Short Anabolic Peptides for Bone Growth.Treatment of a segmental defect in open radial and ulnar shaft fractures using rhBMP-2 and iliac crest bone graft: a case report.Bone morphogenetic proteins and osseointegration: current knowledge - future possibilities.Enhanced bone healing using collagen-hydroxyapatite scaffold implantation in the treatment of a large multiloculated mandibular aneurysmal bone cyst in a thoroughbred filly.BMP2-induced inflammation can be suppressed by the osteoinductive growth factor NELL-1.High doses of bone morphogenetic protein 2 induce structurally abnormal bone and inflammation in vivo.Effects of protein dose and delivery system on BMP-mediated bone regeneration.Controlled release of BMP-2 using a heparin-conjugated carrier system reduces in vivo adipose tissue formation.Controlled delivery of low-dose bone morphogenetic protein-2 using heparin-conjugated fibrin in the posterolateral lumbar fusion of rabbits.Cyst-Like Osteolytic Formations in Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2) Augmented Sheep Spinal Fusion.Bone union rate with recombinant human bone morphogenic protein-2 versus autologous iliac bone in PEEK cages for anterior lumbar interbody fusion.Rare complications of osteolysis and periprosthetic tissue reactions after hybrid and non-hybrid total disc replacement.
P2860
Q28081370-1E059C10-FD6F-41D0-B09A-A83FE4130AFFQ28547838-F23CC1B4-5AB6-41C4-A879-FC7C193A36B6Q33642730-ADF2FFF9-9453-4F52-878E-A93A31F39DE8Q33827070-890BF31C-F4A0-4242-B29E-53882301DE53Q33892364-63B5792C-63A2-4844-B433-319DC08ECE52Q33940869-BA52F17B-72A0-4DCD-98A7-FDAE7C1F9938Q34446441-9808AC9D-E61C-4726-94B7-6467884CAE7EQ34512256-1B5F493B-5C14-4E4B-BFFD-5FDA54ACF44EQ34715389-D00C4E1C-2165-4223-A21D-CA0ED84711C9Q34941544-8ABF5AA1-83D9-45FE-9692-09E23A73D9F3Q34973873-8DEFE9D5-BEE5-4852-9CF9-EDD00A9CCA64Q35598154-D5D750BC-C80C-40B2-AD33-349571612A92Q35605753-D8F4C802-CEAF-4CC9-B166-F86603970475Q35629546-90723D1F-6C73-4F77-8839-56D97E9FD3FDQ35866474-E30AB2B5-681E-4FD9-AEFB-83A7C5BF9F02Q36509203-AA3DFE5D-AC43-4262-A777-804474300254Q36885933-2B7443CB-780C-4EDB-97EE-0CC0E3ED9332Q37030595-FA9BD019-B9C9-4BC3-96AF-5E21B4DAC423Q37109477-E1AA8F72-424E-4698-BC07-BB180E857CE0Q37439946-CC69B5A1-436E-4EE7-B9FB-E220FC52F98CQ37614319-BF01BAF0-7FAD-42F8-B603-A50FE42D3326Q37624440-086736AF-475E-40C2-B1C2-3288828A9FDDQ37774494-5E1E2547-47A7-4272-BBCF-189DB165C0D8Q38014246-98CCBB8E-647B-468C-85BF-01799B60491DQ38039929-4EDB61D0-644F-499D-95FA-F7E2AE10CEDBQ38346225-8BB43F98-51AD-4D51-A023-E6D67055A4D0Q38429540-CAC7BD72-7902-4B52-A211-3913E6F1501EQ38767526-E0E706E1-4930-4507-A794-E1157C26BE2FQ38864194-C0EFC939-A763-4F73-A83A-0CD2FEC37EAAQ39026729-FA26BFBF-7A4A-4673-8DCC-DEA915C92847Q40102684-2097A1B3-22F7-4E2A-91A3-0BFE4AEA386BQ41355477-E7BF6507-1F7F-46A5-BB61-01E4D4B40C56Q41982013-79AEA0D9-8875-40BA-8934-8614E73C009FQ42094508-E26C879C-99E2-48E5-87BD-E7BFF39C123EQ42787240-FC1FB641-AA8B-419C-8AA2-2167AA04BC42Q46285077-CA9E79C2-DF75-4EAD-B65D-5A3C8899FB57Q46890674-A7CE4BC6-634F-48CE-B49C-A5610172DA1EQ51002957-DE51D404-4B84-4B4C-A870-26F99C35C9EBQ53075345-6B7AC7D5-BFD1-4FCC-83B9-0DE74C51AA50Q53463125-AB71AF68-671D-467D-A67F-CC02C45B2C3F
P2860
Use of recombinant human bone morphogenetic protein-2 in spinal fusion applications.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Use of recombinant human bone morphogenetic protein-2 in spinal fusion applications.
@ast
Use of recombinant human bone morphogenetic protein-2 in spinal fusion applications.
@en
Use of recombinant human bone morphogenetic protein-2 in spinal fusion applications.
@nl
type
label
Use of recombinant human bone morphogenetic protein-2 in spinal fusion applications.
@ast
Use of recombinant human bone morphogenetic protein-2 in spinal fusion applications.
@en
Use of recombinant human bone morphogenetic protein-2 in spinal fusion applications.
@nl
prefLabel
Use of recombinant human bone morphogenetic protein-2 in spinal fusion applications.
@ast
Use of recombinant human bone morphogenetic protein-2 in spinal fusion applications.
@en
Use of recombinant human bone morphogenetic protein-2 in spinal fusion applications.
@nl
P1433
P1476
Use of recombinant human bone morphogenetic protein-2 in spinal fusion applications.
@en
P2093
Bill McKay
Harvinder S Sandhu
P304
P356
10.1097/00007632-200208151-00014
P407
P433
16 Suppl 1
P577
2002-08-01T00:00:00Z